blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2157089

EP2157089 - The therapeutic uses of imidazol-5-carboxylic acid derivatives [Right-click to bookmark this link]
Former [2010/08]THE THERAPEUTIC USES OF IMIDAZOL-5-CARBOXYLIC ACID DERIVATIVES
[2013/10]
StatusNo opposition filed within time limit
Status updated on  20.06.2014
Database last updated on 02.09.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Salubris Asset Management Co. Ltd.
1921 Anhui Building, Shennan Road
Futian District
Shenzhen
Guangdong 518040 / CN
[2013/33]
Former [2013/13]For all designated states
Salubris Asset Management Co. Ltd.
1921 Anhui Building, Shennan Road
Futian District
Shenzhen
Guangdong 518040 / CN
Former [2010/08]For all designated states
Shanghai Allist Pharmaceutical., Inc.
1118 Halei Road 5th Floor Zhangjiang High-Tech Park
Shanghai 201210 / CN
Inventor(s)01 / GUO, Jianhui
5th Floor, 1118 Halei Road
Zhangjiang High-tech Park
Shanghai 201210 / CN
 [2013/33]
Former [2010/08]01 / GUO, Jianhui
5th Floor, 1118 Halei Road Zhangjiang High-tech Park
Shanghai 201210 / CN
Representative(s)Gulde & Partner, et al
Patent- und Rechtsanwaltskanzlei mbB
Wallstrasse 58/59
10179 Berlin / DE
[N/P]
Former [2013/32]Gulde Hengelhaupt Ziebig & Schneider, et al
Patentanwälte - Rechtsanwälte Wallstrasse 58/59
10179 Berlin / DE
Former [2010/08]Boff, James Charles, et al
Phillips & Leigh 5 Pemberton Row
GB-London EC4A 3BA / GB
Application number, filing date08757624.506.06.2008
[2010/08]
WO2008CN71213
Priority number, dateCN200719385207.06.2007         Original published format: CN200710093852
[2010/08]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008148359
Date:11.12.2008
Language:ZH
[2008/50]
Type: A1 Application with search report 
No.:EP2157089
Date:24.02.2010
Language:EN
[2010/08]
Type: B1 Patent specification 
No.:EP2157089
Date:14.08.2013
Language:EN
[2013/33]
Search report(s)International search report - published on:CN11.12.2008
(Supplementary) European search report - dispatched on:EP20.07.2011
ClassificationIPC:C07D403/10, A61K31/4178, A61P9/00, A61P9/04, A61P9/10, A61P13/12, A61P9/14, A61P35/00, A61P7/02, A61K9/00, A61K9/70, A61K9/20, A61K9/48, A61K9/16, A61K9/10, A61K9/107, A61K9/08
[2010/08]
CPC:
C07D403/10 (EP,US); A61K31/4178 (EP,US); A61K9/2027 (EP,US);
A61K9/2054 (EP,US); A61K9/4866 (EP,US); A61P13/12 (EP);
A61P25/00 (EP); A61P35/00 (EP); A61P7/02 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP); A61P9/14 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/08]
TitleGerman:Therapeutische Anwendungen von Imidazol-5-Carbonsäurederivaten[2013/10]
English:The therapeutic uses of imidazol-5-carboxylic acid derivatives[2013/10]
French:Utilisations thérapeutiques de dérivés d'acide imidazol-5-carboxylique.[2013/10]
Former [2010/08]THERAPEUTISCHE ANWENDUNGEN VON IMIDAZOL-5-CARBONSÄUREDERIVATEN
Former [2010/08]THE THERAPEUTIC USES OF IMIDAZOL-5-CARBOXYLIC ACID DERIVATIVES
Former [2010/08]UTILISATIONS THÉRAPEUTIQUES DE DÉRIVÉS D'ACIDE IMIDAZOL-5-CARBOXYLIQUE
Entry into regional phase09.12.2009Translation filed 
09.12.2009National basic fee paid 
09.12.2009Search fee paid 
09.12.2009Designation fee(s) paid 
09.12.2009Examination fee paid 
Examination procedure09.12.2009Examination requested  [2010/08]
17.02.2012Amendment by applicant (claims and/or description)
28.06.2012Despatch of a communication from the examining division (Time limit: M04)
26.10.2012Reply to a communication from the examining division
08.02.2013Communication of intention to grant the patent
06.06.2013Fee for grant paid
06.06.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.06.2012
Opposition(s)15.05.2014No opposition filed within time limit [2014/30]
Fees paidRenewal fee
04.05.2010Renewal fee patent year 03
13.06.2011Renewal fee patent year 04
14.06.2012Renewal fee patent year 05
27.06.2013Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.06.2008
AT14.08.2013
BE14.08.2013
BG14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
HR14.08.2013
IT14.08.2013
LT14.08.2013
LV14.08.2013
MC14.08.2013
MT14.08.2013
NL14.08.2013
PL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
TR14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
[2016/33]
Former [2016/32]HU06.06.2008
AT14.08.2013
BE14.08.2013
BG14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
HR14.08.2013
IT14.08.2013
LT14.08.2013
LV14.08.2013
MC14.08.2013
MT14.08.2013
NL14.08.2013
PL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2016/25]AT14.08.2013
BE14.08.2013
BG14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
HR14.08.2013
IT14.08.2013
LT14.08.2013
LV14.08.2013
MC14.08.2013
MT14.08.2013
NL14.08.2013
PL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2016/16]AT14.08.2013
BE14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
HR14.08.2013
IT14.08.2013
LT14.08.2013
LV14.08.2013
MC14.08.2013
MT14.08.2013
NL14.08.2013
PL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2015/09]AT14.08.2013
BE14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
HR14.08.2013
IT14.08.2013
LT14.08.2013
LV14.08.2013
MC14.08.2013
NL14.08.2013
PL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/24]AT14.08.2013
BE14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
ES14.08.2013
FI14.08.2013
HR14.08.2013
IT14.08.2013
LT14.08.2013
LV14.08.2013
NL14.08.2013
PL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/23]AT14.08.2013
BE14.08.2013
CY14.08.2013
CZ14.08.2013
DK14.08.2013
EE14.08.2013
FI14.08.2013
HR14.08.2013
LT14.08.2013
LV14.08.2013
NL14.08.2013
PL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
SK14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/22]AT14.08.2013
BE14.08.2013
CY14.08.2013
DK14.08.2013
FI14.08.2013
HR14.08.2013
LT14.08.2013
LV14.08.2013
NL14.08.2013
PL14.08.2013
RO14.08.2013
SE14.08.2013
SI14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/21]AT14.08.2013
BE14.08.2013
CY14.08.2013
DK14.08.2013
FI14.08.2013
HR14.08.2013
LT14.08.2013
LV14.08.2013
PL14.08.2013
SE14.08.2013
SI14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/18]AT14.08.2013
BE14.08.2013
CY14.08.2013
FI14.08.2013
HR14.08.2013
LT14.08.2013
LV14.08.2013
PL14.08.2013
SE14.08.2013
SI14.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/14]AT14.08.2013
BE14.08.2013
FI14.08.2013
HR14.08.2013
LT14.08.2013
LV14.08.2013
PL14.08.2013
SE14.08.2013
SI14.08.2013
CY21.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/12]AT14.08.2013
FI14.08.2013
HR14.08.2013
LT14.08.2013
LV14.08.2013
PL14.08.2013
SE14.08.2013
SI14.08.2013
CY21.08.2013
NO14.11.2013
GR15.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/11]AT14.08.2013
FI14.08.2013
HR14.08.2013
LT14.08.2013
PL14.08.2013
SE14.08.2013
CY21.08.2013
NO14.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/10]AT14.08.2013
HR14.08.2013
LT14.08.2013
SE14.08.2013
CY21.08.2013
NO14.11.2013
IS14.12.2013
PT16.12.2013
Former [2014/09]AT14.08.2013
HR14.08.2013
LT14.08.2013
SE14.08.2013
NO14.11.2013
PT16.12.2013
Former [2014/08]LT14.08.2013
NO14.11.2013
PT16.12.2013
Former [2014/07]NO14.11.2013
Documents cited:Search[E]EP1988090  (SHANGHAI ALLIST PHARMACEUTICAL [CN]) [E] 1-8,10 * page 4, lines 48,49 * * page 16; example 12; compound 8 * * claim 6 * * page 10, paragraph 33 * * page 2, paragraph 1 * * page 4, paragraphs 15,16 * * page 9, paragraph 23 *;
 [E]EP2116242  (SHANGHAI ALLIST PHARMACEUTICAL [CN]) [E] 1-10 * claims 1,9-13, 15 *;
 [I]EP0535420  (CHEM PHARM FORSCH GMBH [AT]) [I] 1-10 * pages 17, 18; claims 5, 9, 10 * * page 5; example 1 *;
 [A]  - Sabine Wolf ET AL, "Sind alle Antihypertensiva nephroprotectiv?", Herz, doi:10.1007/s00059-003-2508-6, (20040101), pages 248 - 254, URL: http://www.springerlink.com/content/qgb6wxngnnctpagk/fulltext.pdf, (20110706), XP055002057 [A] 1-10 * abstract * * pages 251, 252 *

DOI:   http://dx.doi.org/10.1007/s00059-003-2508-6
 [A]  - B Dahlöf, "End-organ damage: does it really matter how we prevent it?", European Heart Journal Supplements, (20030101), pages F33 - F39, URL: http://eurheartjsupp.oxfordjournals.org/content/5/suppl_F/F33.full.pdf, (20110705), XP055001994 [A] 1-10 * abstract * * page F38 *
 [A]  - GRANDI A M ET AL, "Blockade of the renin-angiotensin-aldosterone system: Effects on hypertensive target organ damage", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (200607), Database accession no. EMB-2006328232, XP002647880 [A] 1-10 * abstract *
    [ ] - CARDIOVASCULAR AND HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY 200607 NL, (200607), vol. 4, no. 3, ISSN 1871-5257, pages 219 - 228
International search[A]  - MA B. ET AL., "Effects of Losartan on cardiac and renal functions in elderly hypertensive patients", JOURNAL OF JINLIN UNIVERSITY (MEDICINE EDITION), (200507), vol. 31, no. 4, pages 620 - 622
ExaminationWO2007095789
by applicantUS5138069
 WO2006CN01914
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.